EverGreen
1 known investors
Evergreen Theragnostics develops theragnostic radiopharmaceuticals aimed at improving treatment options for cancer patients, and also operates as a contract development and manufacturing organization (CDMO). The company was acquired by Lantheus.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does EverGreen do?
- Evergreen Theragnostics develops theragnostic radiopharmaceuticals aimed at improving treatment options for cancer patients, and also operates as a contract development and manufacturing organization (CDMO). The company was acquired by Lantheus.
- Who are EverGreen's investors?
- EverGreen's investors include NovaCapital.